Roche’s Hemlibra Battles Fierce Competition Amid Rating Hold
Roche's Hemlibra braces for fierce competition from Novo Nordisk's mim8, as analysts give mixed ratings and forecasts on Roche's strategic ...
- Latest
- Trending
Roche's Hemlibra braces for fierce competition from Novo Nordisk's mim8, as analysts give mixed ratings and forecasts on Roche's strategic ...
BofA reaffirms Buy rating, $265 target for Zscaler post-Zenith Live 2024, citing strong innovations, strategic shifts, and positive market outlook.
Brighthouse Financial’s stock rating shifted as Piper Sandler cut its price target from $55.00 to $50.00, citing earnings concerns.
The firm maintained its Buy rating despite highlighting a second-half sales increase as crucial to meet yearly targets amid a ...
Ethereum at Rs 3.21 lakh, Dogecoin at Rs 12.23, and Litecoin at Rs 6,959.64; Ripple at $0.4816, Solana at $150.85, ...
Deutsche Bank's 3% DCF growth rate signals GDP alignment; Analyst warns Oracle's rating, target price risks. AI-assisted, editor-reviewed. Learn more ...
Zeta Global sees robust growth with a 23.1% revenue increase, earning "Buy" ratings from major analysts despite a lack of ...
CrediBULL Crypto predicts Ethereum to hit $10,000, despite recent declines. Key levels: $3,399 support, $3,668 initial resistance. Eyes on ETH's ...
Crypto Market Woes: Bitcoin Falls to $65K, Ethereum Stabilizes at $3,509 Amid Whale Accumulation; Can ETH Rally to $3,900?
ETFswap (ETFS) gains spotlight as Musk’s 2021 tweet ignites interest. Dogecoin and Grok valuations noted. Investors urged to explore altcoins.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.